Evidence map›Paper›PMID 32235300›Full record

ReviewInternational journal of molecular sciences2020

The Role of Chondrocyte Hypertrophy and Senescence in Osteoarthritis Initiation and Progression.

Yeri Alice Rim, Yoojun Nam, Ji Hyeon Ju

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 231 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yeri Alice RimCatholic iPSC Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-9541-3075
Yoojun NamCatholic iPSC Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Ji Hyeon JuCatholic iPSC Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Funding

National Research Foundation of Korea 2019R1I1A1A01060753National Research Foundation of Korea 2019R1I1A1A01062060
6 · The paper itself

Abstract

Osteoarthritis (OA) is the most common joint disease that causes pain and disability in the adult population. OA is primarily caused by trauma induced by an external force or by age-related cartilage damage. Chondrocyte hypertrophy or chondrocyte senescence is thought to play a role in the initiation and progression of OA. Although chondrocyte hypertrophy and cell death are both crucial steps during the natural process of endochondral bone formation, the abnormal activation of these two processes after injury or during aging seems to accelerate the progression of OA. However, the exact mechanisms of OA progression and these two processes remain poorly understood. Chondrocyte senescence and hypertrophy during OA share various markers and processes. In this study, we reviewed the changes that occur during chondrocyte hypertrophy or senescence in OA and the attempts that were made to regulate them. Regulation of hypertrophic or senescent chondrocytes might be a potential therapeutic target to slow down or stop OA progression; thus, a better understanding of the processes is required for management.

Indexed as

Cellular SenescenceDisease SusceptibilityAnimalsBiomarkersCartilage, ArticularCell DifferentiationCell ProliferationChondrocytesChondrogenesisDisease ProgressionGene Expression RegulationHumansHypertrophyOsteoarthritisOsteogenesisSignal TransductionBiomarkersarticular cartilagechondrocytehypertrophyosteoarthritissenescence

Identifiers

PMID32235300
PMCPMC7177949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.